- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Scpharmaceuticals Inc (SCPH)
Scpharmaceuticals Inc stock price live, this page displays NASDAQ SCPH stock exchange data. View the SCPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Scpharmaceuticals Inc real time stock price chart below.
What Is the Scpharmaceuticals Inc Stock Price Today?
The Scpharmaceuticals Inc stock price today is 5.670.
What Is the Stock Symbol for Scpharmaceuticals Inc?
The stock symbol for Scpharmaceuticals Inc is ""SCPH.""
What Stock Exchange Does Scpharmaceuticals Inc Trade On?
Scpharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Scpharmaceuticals Inc a Good Stock to Buy?
Determining whether Scpharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SCPH quote. (ISIN: US8106481059)
What Is the Scpharmaceuticals Inc Stock Price Today?
The Scpharmaceuticals Inc stock price today is 5.670.
What Is the Stock Symbol for Scpharmaceuticals Inc?
The stock symbol for Scpharmaceuticals Inc is ""SCPH.""
What Stock Exchange Does Scpharmaceuticals Inc Trade On?
Scpharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is Scpharmaceuticals Inc a Good Stock to Buy?
Determining whether Scpharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SCPH quote. (ISIN: US8106481059)
5.670
0.000(0.00%)
Closed·
Fair Value
An estimate of a Scpharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.650
5.705
52 wk Range
1.940
6.280
SCPH Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Unusual trading volume
1/2
Fair Value
An estimate of a Scpharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.6505.705
52 wk Range
1.9406.280
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SCPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Scpharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
5.675
Upside
+0.09%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- scPharmaceuticals receives Investment Bank Analyst Rating Update
- Investing.com
Pro - scPharmaceuticals receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Scpharmaceuticals Inc Company Profile
scPharmaceuticals Inc., a pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care. The company’s lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for the treatment of congestion due to fluid overload in adults with chronic heart failure and kidney disease, as well as consists of subcutaneous loop diuretic that delivers IV equivalent diuresis at home; and FUROSCIX On-Body Infusor, a drug-device combination product consisting of FUROSCIX. Its product pipeline also includes SCP-111 (furosemide injection), an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home; and SCP-111 Autoinjector, an investigational single-entity and drug-device combination product candidate consisting of a prefilled syringe containing SCP-111 preloaded into a mechanical autoinjector. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts. As of October 7, 2025, scPharmaceuticals Inc. operates as a subsidiary of MannKind Corporation.
Scpharmaceuticals Inc Earnings Call Summary for Q2/2025
- Revenue surged 99% YoY to $16M, driven by strong Ferosex demand in nephrology, but EPS missed at -$0.34 vs -$0.29 forecast
- Stock dropped 11.98% to $4.63 in after-hours trading, reflecting investor concerns over profitability and cash flow challenges
- Cash reserves decreased to $40.8M from $75.5M, raising potential liquidity concerns despite revenue growth
- Company expects continued growth in Q3, plans sNDA submission for auto injector, and implemented 3.5% price increase on July 1
- CEO remains confident in scaling ability; analysts question CKD launch trajectory and Medicare Part B payment model proposal
Last Updated: 21/08/2025, 13:46
Read Full TranscriptCompare SCPH to Peers and Sector
Metrics to compare | SCPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSCPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.3x | −5.2x | −0.7x | |
PEG Ratio | 0.25 | −0.03 | 0.00 | |
Price/Book | −14.3x | 0.6x | 2.6x | |
Price / LTM Sales | 6.1x | 1.9x | 3.4x | |
Upside (Analyst Target) | 5.8% | 20.5% | 35.7% | |
Fair Value Upside | Unlock | 12.0% | 4.1% | Unlock |
Analyst Ratings
0 Buy
3 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 5.675
(+0.09% Upside)
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
-0.34 / -0.29
Revenue / Forecast
16.00M / 15.41M
People Also Watch
FAQ
What Stock Exchange Does Scpharmaceuticals Trade On?
Scpharmaceuticals is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Scpharmaceuticals?
The stock symbol for Scpharmaceuticals is "SCPH."
What Is the Scpharmaceuticals Market Cap?
As of today, Scpharmaceuticals market cap is 304.83M.
What Is Scpharmaceuticals's Earnings Per Share (TTM)?
The Scpharmaceuticals EPS (TTM) is -1.77.
When Is the Next Scpharmaceuticals Earnings Date?
Scpharmaceuticals will release its next earnings report on 04 Nov 2025.
From a Technical Analysis Perspective, Is SCPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Scpharmaceuticals Stock Split?
Scpharmaceuticals has split 0 times.
How Many Employees Does Scpharmaceuticals Have?
Scpharmaceuticals has 163 employees.
What is the current trading status of Scpharmaceuticals (SCPH)?
As of 09 Oct 2025, Scpharmaceuticals (SCPH) is trading at a price of 5.670, with a previous close of 5.67. The stock has fluctuated within a day range of 5.650 to 5.705, while its 52-week range spans from 1.940 to 6.280.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.